Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM)

76 filings reported holding CLYM - Climb Bio, Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 54.7M shares of 67.8M outstanding shares and own 80.66% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (31.4M shares), JANUS HENDERSON GROUP PLC (3.61M shares), Samsara BioCapital, LLC (2.61M shares), Boxer Capital, LLC (2.6M shares), Deep Track Capital, LP (2.17M shares), BlackRock, Inc. (1.87M shares), VANGUARD GROUP INC (1.52M shares), Affinity Asset Advisors, LLC (1.5M shares), Ally Bridge Group (NY) LLC (1.23M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (673K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.